Bruker Stock Price, News & Analysis (NASDAQ:BRKR)

$34.28 0.01 (0.03 %)
(As of 12/13/2017 05:36 AM ET)
Previous Close$34.27
Today's Range$34.12 - $34.58
52-Week Range$21.03 - $36.53
Volume500,800 shs
Average Volume627,653 shs
Market Capitalization$5.33 billion
P/E Ratio29.29
Dividend Yield0.46%
Beta1.12

About Bruker (NASDAQ:BRKR)

Bruker logoBruker Corporation designs and manufactures scientific instruments, and analytical and diagnostic solutions. Its segments include the Bruker BioSpin Group; the Bruker Chemicals, Applied Markets, Life Science, In-Vitro Diagnostics, Detection (CALID) Group; the Bruker Nano Group, and the Bruker Energy & Supercon Technologies (BEST) Segment. The Bruker BioSpin Group segment designs, manufactures and distributes enabling life science tools. The Bruker CALID segment designs, manufactures and distributes life science mass spectrometry instruments that can be integrated and used along with other sample preparation or chromatography instruments, as well as chemical, biological, radiological, nuclear and explosive detection products. The Bruker Nano segment designs, manufactures and distributes spectroscopy and microscopy instruments. The BEST segment develops and manufactures superconducting and non-superconducting materials and devices. It also focuses on nanomechanical testing instruments.

Receive BRKR News and Ratings via Email

Sign-up to receive the latest news and ratings for BRKR and its competitors with MarketBeat's FREE daily newsletter.

Industry, Sector and Symbol

Industry Advanced Medical Equipment & Technology
Sub-IndustryLife Sciences Tools & Services
SectorComputer and Technology
SymbolNASDAQ:BRKR
CUSIP11679410
Phone978-663-3660

Debt

Debt-to-Equity Ratio0.65%
Current Ratio2.60%
Quick Ratio1.60%

Price-To-Earnings

Trailing P/E Ratio29.29
Forward P/E Ratio28.81
P/E Growth2.9

Sales & Book Value

Annual Sales$1.61 billion
Price / Sales3.31
Cash Flow$1.54 per share
Price / Cash22.29
Book Value$4.32 per share
Price / Book7.94

Profitability

Trailing EPS$0.94
Net Income$153.60 million
Net Margins8.85%
Return on Equity25.83%
Return on Assets10.05%

Miscellaneous

Employees6,000
Outstanding Shares155,560,000

Bruker (NASDAQ:BRKR) Frequently Asked Questions

What is Bruker's stock symbol?

Bruker trades on the NASDAQ under the ticker symbol "BRKR."

How often does Bruker pay dividends? What is the dividend yield for Bruker?

Bruker declared a quarterly dividend on Monday, November 13th. Stockholders of record on Monday, December 4th will be given a dividend of $0.04 per share on Friday, December 22nd. This represents a $0.16 annualized dividend and a dividend yield of 0.47%. The ex-dividend date is Friday, December 1st. View Bruker's Dividend History.

How will Bruker's stock buyback program work?

Bruker declared that its Board of Directors has approved a stock buyback program on Sunday, June 4th 2017, which permits the company to buyback $225,000,000.00 in shares, according to EventVestor. This buyback authorization permits the company to purchase shares of its stock through open market purchases. Stock buyback programs are usually a sign that the company's board of directors believes its stock is undervalued.

How were Bruker's earnings last quarter?

Bruker Co. (NASDAQ:BRKR) issued its earnings results on Thursday, November, 2nd. The medical research company reported $0.29 earnings per share for the quarter, beating the Thomson Reuters' consensus estimate of $0.27 by $0.02. The medical research company had revenue of $435.60 million for the quarter, compared to the consensus estimate of $415.45 million. Bruker had a return on equity of 25.83% and a net margin of 8.85%. The company's revenue for the quarter was up 10.6% compared to the same quarter last year. During the same quarter in the prior year, the firm posted $0.32 EPS. View Bruker's Earnings History.

When will Bruker make its next earnings announcement?

Bruker is scheduled to release their next quarterly earnings announcement on Monday, February, 12th 2018. View Earnings Estimates for Bruker.

Where is Bruker's stock going? Where will Bruker's stock price be in 2017?

14 brokers have issued 1-year target prices for Bruker's stock. Their forecasts range from $24.00 to $34.00. On average, they anticipate Bruker's stock price to reach $28.90 in the next twelve months. View Analyst Ratings for Bruker.

What are Wall Street analysts saying about Bruker stock?

Here are some recent quotes from research analysts about Bruker stock:

  • 1. According to Zacks Investment Research, "Bruker exited the third quarter on a solid note with better-than-expected earnings and revenue performance. Scientific Instruments segment performed well where growth was driven by strong results within NANO and CALID groups. The company also raised 2017 guidance, which is indicative of brighter prospects. Moving on, the company’s strategic acquisition activity has been encouraging. In this context, the company recently announced the completion of acquisition of Germany-based MERLIN whose products can complement Bruker’s MALDI Biotyper platform. Following its promising third quarter 2017 performance, Bruker has been observed to trade above the broader industry over the past three months. On the flip side, currency fluctuations, competitive landscape and macroeconomic headwinds continue to pose challenges for the company." (11/10/2017)
  • 2. Jefferies Group LLC analysts commented, "4Q16 EPS walloped consensus (+9c / +4c operational), while the initial 2017 EPS outlook bracketed consensus. Commentary pointed to further signs of endmarket stability as EU orders turned positive in 4Q (first time all yr). Net-net, BRKR is managing the P&L better than it ever has, and with end-mkts steadily improving, we like the risk/reward & see room for upside. We modestly raise our '17/18 EPS by +1c/+5c (to $1.08/$1.30)." (2/14/2017)
  • 3. Evercore ISI analysts commented, "Bruker continues to execute well across its business, delivering on impressive GM expansion, while continuing OpEx rationalization and stepping up capital allocation. Thus in terms of what management can control they are doing an excellent job and certainly have delivered much of what shareholders demanded several years ago. That being said end markets remain not fully cooperative, and while EU academic has improved it is off of depressed levels. Given this dynamic core growth remains constrained and in a year where the growth comparable is tough due to tax savings the current outlook for EPS upside is mixed. With shares trading north of 20x we contend that visibility back to 3-5% core growth must improve, and we look for further check points from management in the first part of 2017. We think if bookings momentum continues to accelerate over the next few quarters that will be the signal to get incrementally constructive on shares. Therefore we await additional proof points and in the near-term remain on the sidelines." (2/14/2017)

Who are some of Bruker's key competitors?

Who are Bruker's key executives?

Bruker's management team includes the folowing people:

  • Frank H. Laukien Ph.D., Chairman of the Board, President, Chief Executive Officer (Age 57)
  • Anthony L. Mattacchione, Chief Financial Officer, Senior Vice President (Age 54)
  • Juergen Srega, President of Bruker CALID Group and Bruker Daltonics Division (Age 62)
  • Mark Robert Munch Ph.D., Executive Vice President - President of Bruker Nano Group and Bruker Nano Surfaces Division (Age 55)
  • William A. Linton, Lead Independent Director (Age 69)
  • Joerg C. Laukien, Director (Age 63)
  • Cynthia M. Friend Ph.D., Independent Director (Age 62)
  • Marc A. Kastner Ph.D., Independent Director (Age 71)
  • Richard D. Kniss, Independent Director (Age 76)

Who owns Bruker stock?

Bruker's stock is owned by many different of retail and institutional investors. Top institutional shareholders include Boston Partners (1.36%), Victory Capital Management Inc. (1.21%), Russell Investments Group Ltd. (0.97%), Dimensional Fund Advisors LP (0.59%), Wells Fargo & Company MN (0.53%) and First Quadrant L P CA (0.52%). Company insiders that own Bruker stock include Frank H Laukien, Ingen Chris Van, Joerg C Laukien, Mark Munch, Richard A Packer, Richard Kniss and Wolf-Dieter Emmerich. View Institutional Ownership Trends for Bruker.

Who sold Bruker stock? Who is selling Bruker stock?

Bruker's stock was sold by a variety of institutional investors in the last quarter, including Boston Partners, Cambiar Investors LLC, Russell Investments Group Ltd., Canada Pension Plan Investment Board, Allianz Asset Management GmbH, California State Teachers Retirement System, Cornerstone Capital Management Holdings LLC. and New York State Common Retirement Fund. Company insiders that have sold Bruker company stock in the last year include Ingen Chris Van, Mark Munch and Richard Kniss. View Insider Buying and Selling for Bruker.

Who bought Bruker stock? Who is buying Bruker stock?

Bruker's stock was acquired by a variety of institutional investors in the last quarter, including First Trust Advisors LP, Prudential Financial Inc., Fisher Asset Management LLC, Citadel Advisors LLC, Janus Henderson Group PLC, GSA Capital Partners LLP, Palisade Capital Management LLC NJ and Jennison Associates LLC. Company insiders that have bought Bruker stock in the last two years include Frank H Laukien and Richard A Packer. View Insider Buying and Selling for Bruker.

How do I buy Bruker stock?

Shares of Bruker can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include Vanguard Brokerage Services, TD Ameritrade, E*TRADE, Scottrade, Fidelity and Charles Schwab.

What is Bruker's stock price today?

One share of Bruker stock can currently be purchased for approximately $34.28.

How big of a company is Bruker?

Bruker has a market capitalization of $5.33 billion and generates $1.61 billion in revenue each year. The medical research company earns $153.60 million in net income (profit) each year or $0.94 on an earnings per share basis. Bruker employs 6,000 workers across the globe.

How can I contact Bruker?

Bruker's mailing address is 40 Manning Road, Billerica MA, 01821. The medical research company can be reached via phone at 978-663-3660 or via email at [email protected]


MarketBeat Community Rating for Bruker (BRKR)

Community Ranking:  2.3 out of 5 (star star)
Outperform Votes:  291 (Vote Outperform)
Underperform Votes:  351 (Vote Underperform)
Total Votes:  642
MarketBeat's community ratings are surveys of what our community members think about Bruker and other stocks. Vote "Outperform" if you believe the stock will outperform the S&P 500 over the long term. Vote "Underperform" if you believe the stock will underperform the S&P 500 over the long term. You may vote once every thirty days.

Analyst Ratings

Bruker (NASDAQ:BRKR) Analysts' Consensus Rating

  (How are Consensus Ratings Calculated?)
Today30 Days Ago90 Days Ago180 Days Ago
Consensus Rating: HoldHoldHoldHold
Consensus Rating Score: 2.062.062.132.11
Ratings Breakdown: 2 Sell Rating(s)
12 Hold Rating(s)
3 Buy Rating(s)
0 Strong Buy Rating(s)
2 Sell Rating(s)
12 Hold Rating(s)
3 Buy Rating(s)
0 Strong Buy Rating(s)
2 Sell Rating(s)
10 Hold Rating(s)
4 Buy Rating(s)
0 Strong Buy Rating(s)
2 Sell Rating(s)
12 Hold Rating(s)
4 Buy Rating(s)
0 Strong Buy Rating(s)
Consensus Price Target: $27.43$27.43$25.92$25.47
Price Target Upside: 17.73% downside17.73% downside11.16% downside1.25% downside

Bruker (NASDAQ:BRKR) Consensus Price Target History

Price Target History for Bruker (NASDAQ:BRKR)

Bruker (NASDAQ:BRKR) Analyst Ratings History

Show:
DateBrokerageActionRatingPrice TargetImpact on Share PriceDetails
11/3/2017CitigroupBoost Price TargetNeutral$29.00 -> $34.00N/AView Rating Details
11/3/2017CowenReiterated RatingHold$29.00N/AView Rating Details
11/3/2017Bank of AmericaUpgradeUnderperform -> Neutral$34.00N/AView Rating Details
11/3/2017J P Morgan Chase & CoUpgradeUnderweight -> Neutral$28.00N/AView Rating Details
9/26/2017Goldman Sachs GroupReiterated RatingSell -> Sell$24.00LowView Rating Details
7/17/2017BarclaysReiterated RatingEqual Weight$26.00 -> $30.00LowView Rating Details
7/12/2017Wells Fargo & CompanyDowngradeMarket Perform -> UnderperformMediumView Rating Details
5/15/2017Jefferies GroupReiterated RatingBuy$29.00N/AView Rating Details
5/15/2017Deutsche BankBoost Price TargetHold$25.00 -> $27.00N/AView Rating Details
4/27/2017Cleveland ResearchUpgradeNeutral -> BuyHighView Rating Details
3/27/2017Janney Montgomery ScottDowngradeBuy -> NeutralLowView Rating Details
2/15/2017BTIG ResearchReiterated RatingHoldN/AView Rating Details
2/14/2017Cantor FitzgeraldSet Price TargetBuy$28.00N/AView Rating Details
2/14/2017Evercore ISIBoost Price TargetHold$23.50 -> $26.00N/AView Rating Details
11/10/2016Leerink SwannInitiated CoverageMarket Perform$21.00N/AView Rating Details
8/3/2016Morgan StanleySet Price TargetHold$23.00N/AView Rating Details
8/3/2016MizuhoLower Price TargetNeutral$28.00 -> $23.00N/AView Rating Details
3/14/2016Stifel NicolausBoost Price TargetBuy$25.00 -> $32.00N/AView Rating Details
1/6/2016Avondale PartnersInitiated CoverageMarket Perform$26.00N/AView Rating Details
(Data available from 12/13/2015 forward)

Earnings

Bruker (NASDAQ:BRKR) Earnings History and Estimates Chart

Earnings by Quarter for Bruker (NASDAQ:BRKR)

Bruker (NASDAQ BRKR) Earnings History by Quarter

DateQuarterConsensus EstimateActual EPSRevenue EstimateActual RevenueRelease LinkConference CallDetails
2/12/2018$0.48N/AView Earnings Details
11/2/2017Q3 2017$0.27$0.29$415.45 million$435.60 millionViewN/AView Earnings Details
8/3/2017Q2 2017$0.20$0.23$384.75 million$414.90 millionViewN/AView Earnings Details
5/3/2017Q1 2017$0.19$0.19$372.59 million$384.90 millionViewN/AView Earnings Details
2/13/2017Q416$0.37$0.46$464.49 million$470.30 millionViewN/AView Earnings Details
11/2/2016Q316$0.20$0.32$394.14 million$393.90 millionViewN/AView Earnings Details
8/2/2016Q216$0.20$0.20$409.57 million$371.70 millionViewN/AView Earnings Details
5/4/2016Q116$0.15$0.21$360.37 million$375.40 millionViewN/AView Earnings Details
2/10/2016Q415$0.27$0.38$469.98 million$478.20 millionViewN/AView Earnings Details
11/4/2015Q315$0.13$0.19$373.65 million$396.10 millionViewN/AView Earnings Details
8/5/2015Q215$0.17$0.19$391.87 million$396.00 millionViewN/AView Earnings Details
5/6/2015Q115$0.10$0.14$369.80 million$353.50 millionViewN/AView Earnings Details
2/19/2015Q414$0.29$0.30$515.50 million$508.00 millionViewN/AView Earnings Details
11/6/2014Q314$0.15$0.14$436.30 million$419.80 millionViewN/AView Earnings Details
8/6/2014Q214$0.19$0.21$457.90 million$457.40 millionViewN/AView Earnings Details
5/7/2014Q114$0.09$0.11$402.04 million$423.70 millionViewN/AView Earnings Details
2/18/2014Q413$0.22$0.31$452.14 million$552.10 millionViewListenView Earnings Details
11/1/2013Q313$0.22$0.20$452.40 million$439.00 millionViewListenView Earnings Details
7/31/2013Q2 2013$0.14$0.18$426.39 million$454.90 millionViewListenView Earnings Details
5/2/2013Q1 2013$0.14$0.08$416.76 million$393.40 millionViewListenView Earnings Details
2/19/2013Q4 2012$0.24$0.28$483.65 million$517.30 millionViewListenView Earnings Details
11/5/2012Q312$0.15$0.28$421.39 million$447.80 millionViewN/AView Earnings Details
7/31/2012$0.12$0.12ViewN/AView Earnings Details
5/1/2012$0.12$0.14ViewN/AView Earnings Details
2/22/2012$0.29$0.31ViewN/AView Earnings Details
10/27/2011$0.22$0.23ViewN/AView Earnings Details
8/3/2011$0.21$0.20ViewN/AView Earnings Details
4/28/2011$0.15$0.14ViewN/AView Earnings Details
2/23/2011$0.27$0.27ViewN/AView Earnings Details
(Data available from 1/1/2011 forward)

Estimates

Bruker (NASDAQ:BRKR) Earnings Estimates

2017 EPS Consensus Estimate: $1.11
2018 EPS Consensus Estimate: $1.32
QuarterNumber of EstimatesLow EstimateHigh EstimateAverage Estimate
Q1 20173$0.18$0.21$0.19
Q2 20173$0.17$0.21$0.19
Q3 20173$0.25$0.30$0.27
Q4 20173$0.42$0.49$0.46
Q1 20183$0.22$0.30$0.25
Q2 20183$0.26$0.32$0.28
Q3 20183$0.32$0.34$0.33
Q4 20183$0.40$0.50$0.45
(Data provided by Zacks Investment Research)

Dividends

Bruker (NASDAQ:BRKR) Dividend Information

Next Dividend:12/22/2017
Annual Dividend:$0.16
Dividend Yield:0.47%
Payout Ratio:17.02% (Trailing 12 Months of Earnings)
13.45% (Based on This Year's Estimates)
12.03% (Based on Next Year's Estimates)
Dividend Payments by Quarter for Bruker (NASDAQ:BRKR)

Bruker (NASDAQ:BRKR) Dividend History by Quarter

AnnouncedPeriodAmountYieldEx-Dividend DateRecord DatePayable Date
11/13/2017quarterly$0.040.49%12/1/201712/4/201712/22/2017
8/14/2017quarterly$0.040.57%8/31/20179/5/20179/22/2017
5/15/2017quarterly$0.040.61%6/1/20176/5/20176/23/2017
2/21/2017quarterly$0.040.65%3/6/20173/8/20173/24/2017
11/15/2016quarterly$0.040.69%12/1/201612/5/201612/23/2016
8/9/2016quarterly$0.040.72%9/1/20169/6/20169/23/2016
5/18/2016quarterly$0.040.61%6/2/20166/6/20166/24/2016
2/22/2016Quarterly$0.043/2/20163/4/20163/24/2016
(Data available from 1/1/2013 forward)

Insider Trades

Bruker (NASDAQ BRKR) Insider Trading and Institutional Ownership History

Insider Ownership Percentage: 35.20%
Institutional Ownership Percentage: 65.63%
Insider Trades by Quarter for Bruker (NASDAQ:BRKR)
Institutional Ownership by Quarter for Bruker (NASDAQ:BRKR)

Bruker (NASDAQ BRKR) Insider Trades by Quarter

Transaction DateInsider NameTitleBuy/SellNumber of SharesAverage Share PriceTotal TransactionDetails
9/13/2017Mark MunchVPSell21,061$29.97$631,198.17View SEC Filing  
8/10/2017Frank H LaukienCEOBuy2,335$27.39$63,955.65View SEC Filing  
6/14/2017Ingen Chris VanDirectorSell19,900$28.03$557,797.00View SEC Filing  
6/13/2017Richard KnissDirectorSell24,000$28.23$677,520.00View SEC Filing  
6/8/2017Mark MunchVPSell73,724$27.62$2,036,256.88View SEC Filing  
5/19/2017Frank H LaukienCEOBuy3,200$26.13$83,616.00View SEC Filing  
5/18/2017Frank H LaukienCEOBuy73,000$26.22$1,914,060.00View SEC Filing  
5/16/2017Frank H LaukienCEOBuy1,920$25.88$49,689.60View SEC Filing  
3/17/2017Frank H LaukienCEOBuy4,300$23.34$100,362.00View SEC Filing  
3/13/2017Frank H LaukienCEOBuy2,300$23.74$54,602.00View SEC Filing  
12/15/2016Frank H LaukienCEOBuy4,725$21.22$100,264.50View SEC Filing  
12/13/2016Ingen Chris VanDirectorSell20,000$22.29$445,800.00View SEC Filing  
11/25/2016Frank H LaukienCEOBuy2,124$22.90$48,639.60View SEC Filing  
8/10/2016Richard A PackerDirectorBuy10,000$21.97$219,700.00View SEC Filing  
8/5/2016Frank H LaukienCEOBuy4,500$22.17$99,765.00View SEC Filing  
6/14/2016Frank H LaukienCEOBuy4,174$23.95$99,967.30View SEC Filing  
6/6/2016Joerg C LaukienDirectorSell2,000,000$25.65$51,300,000.00View SEC Filing  
5/9/2016Wolf-Dieter EmmerichDirectorSell21,000$27.35$574,350.00View SEC Filing  
6/15/2015Frank H LaukienCEOBuy1,000,000$19.50$19,500,000.00View SEC Filing  
6/11/2015Frank H LaukienCEOBuy5,901$20.31$119,849.31View SEC Filing  
6/11/2015Stephen W FesikDirectorSell15,000$20.48$307,200.00View SEC Filing  
3/17/2015Charles F Wagner JrCFOSell19,000$18.97$360,430.00View SEC Filing  
3/5/2015Richard A PackerDirectorBuy15,000$19.00$285,000.00View SEC Filing  
2/25/2015Frank H LaukienCEOBuy5,271$18.95$99,885.45View SEC Filing  
12/14/2012Frank H LaukienCEOBuy50,000$14.68$734,000.00View SEC Filing  
(Data available from 1/1/2013 forward)

Headlines

Bruker (NASDAQ BRKR) News Headlines

Source:
DateHeadline
ETFs with exposure to Bruker Corp. : December 8, 2017ETFs with exposure to Bruker Corp. : December 8, 2017
finance.yahoo.com - December 8 at 5:18 PM
Bruker Corp. :BRKR-US: Earnings Analysis: Q3, 2017 By the Numbers : December 7, 2017Bruker Corp. :BRKR-US: Earnings Analysis: Q3, 2017 By the Numbers : December 7, 2017
finance.yahoo.com - December 7 at 5:52 PM
Bruker Corp. : BRKR-US: Dividend Analysis : December 04th, 2017 (record date) : By the numbers : December 5, 2017Bruker Corp. : BRKR-US: Dividend Analysis : December 04th, 2017 (record date) : By the numbers : December 5, 2017
finance.yahoo.com - December 5 at 5:21 PM
Bruker Co. (BRKR) Receives Average Rating of "Hold" from AnalystsBruker Co. (BRKR) Receives Average Rating of "Hold" from Analysts
www.americanbankingnews.com - November 30 at 11:46 PM
5 Strong Buy Stocks Gaining Momentum5 Strong Buy Stocks Gaining Momentum
finance.yahoo.com - November 28 at 5:23 PM
Bruker Announces Contract For 133 Hand-Held Chemical Detectors from the U.S. National GuardBruker Announces Contract For 133 Hand-Held Chemical Detectors from the U.S. National Guard
finance.yahoo.com - November 28 at 8:07 AM
Derma Sciences (DSCI) and Bruker Corporation (BRKR) Head to Head SurveyDerma Sciences (DSCI) and Bruker Corporation (BRKR) Head to Head Survey
www.americanbankingnews.com - November 19 at 5:22 AM
 Analysts Expect Bruker Corporation (BRKR) Will Announce Quarterly Sales of $506.92 Million Analysts Expect Bruker Corporation (BRKR) Will Announce Quarterly Sales of $506.92 Million
www.americanbankingnews.com - November 18 at 8:48 AM
Bruker Announces Quarterly DividendBruker Announces Quarterly Dividend
finance.yahoo.com - November 14 at 12:27 AM
SHAREHOLDER ALERT - Bronstein, Gewirtz & Grossman, LLC Announces Investigation of Bruker Corporation (BRKR)SHAREHOLDER ALERT - Bronstein, Gewirtz & Grossman, LLC Announces Investigation of Bruker Corporation (BRKR)
finance.yahoo.com - November 14 at 12:27 AM
Bruker Corporation Declares Quarterly Dividend of $0.04 (BRKR)Bruker Corporation Declares Quarterly Dividend of $0.04 (BRKR)
www.americanbankingnews.com - November 13 at 1:04 PM
Q3 2018 Earnings Estimate for Bruker Corporation Issued By Jefferies Group (BRKR)Q3 2018 Earnings Estimate for Bruker Corporation Issued By Jefferies Group (BRKR)
www.americanbankingnews.com - November 13 at 7:26 AM
Bruker declares $0.04 dividendBruker declares $0.04 dividend
seekingalpha.com - November 13 at 7:24 AM
Investors Buy Large Volume of Bruker Corporation Put Options (BRKR)Investors Buy Large Volume of Bruker Corporation Put Options (BRKR)
www.americanbankingnews.com - November 12 at 1:56 AM
Zacks Investment Research Downgrades Bruker Corporation (BRKR) to HoldZacks Investment Research Downgrades Bruker Corporation (BRKR) to Hold
www.americanbankingnews.com - November 12 at 12:22 AM
Bruker's NANO Grows Strong, MERLIN Buyout Holds PromiseBruker's NANO Grows Strong, MERLIN Buyout Holds Promise
finance.yahoo.com - November 11 at 12:12 PM
SHAREHOLDER ALERT: Bronstein, Gewirtz & Grossman, LLC Announces Investigation of Bruker Corporation (BRKR)SHAREHOLDER ALERT: Bronstein, Gewirtz & Grossman, LLC Announces Investigation of Bruker Corporation (BRKR)
finance.yahoo.com - November 10 at 4:17 PM
Glancy Prongay & Murray LLP Commences Investigation on Behalf of Bruker Corporation Investors (BRKR)Glancy Prongay & Murray LLP Commences Investigation on Behalf of Bruker Corporation Investors (BRKR)
finance.yahoo.com - November 10 at 12:38 PM
BRKR INVESTOR ALERT: Law Offices of Howard G. Smith Commences Investigation on Behalf of Bruker Corporation InvestorsBRKR INVESTOR ALERT: Law Offices of Howard G. Smith Commences Investigation on Behalf of Bruker Corporation Investors
finance.yahoo.com - November 10 at 12:38 PM
SHAREHOLDER ALERT: Pomerantz Law Firm Investigates Claims On Behalf of Investors of Bruker Corporation - BRKRSHAREHOLDER ALERT: Pomerantz Law Firm Investigates Claims On Behalf of Investors of Bruker Corporation - BRKR
finance.yahoo.com - November 10 at 12:38 PM
FY2017 Earnings Estimate for Bruker Corporation Issued By Jefferies Group (BRKR)FY2017 Earnings Estimate for Bruker Corporation Issued By Jefferies Group (BRKR)
www.americanbankingnews.com - November 10 at 8:34 AM
FY2017 EPS Estimates for Bruker Corporation Boosted by Analyst (BRKR)FY2017 EPS Estimates for Bruker Corporation Boosted by Analyst (BRKR)
www.americanbankingnews.com - November 9 at 8:30 AM
Bruker Corporation (BRKR) Upgraded to Buy at Zacks Investment ResearchBruker Corporation (BRKR) Upgraded to Buy at Zacks Investment Research
www.americanbankingnews.com - November 8 at 5:45 PM
Bruker (BRKR) in Focus: Stock Moves 6.5% HigherBruker (BRKR) in Focus: Stock Moves 6.5% Higher
finance.yahoo.com - November 6 at 5:53 PM
Bruker Corporation (BRKR) Expected to Earn Q1 2018 Earnings of $0.23 Per ShareBruker Corporation (BRKR) Expected to Earn Q1 2018 Earnings of $0.23 Per Share
www.americanbankingnews.com - November 6 at 10:40 AM
FY2017 EPS Estimates for Bruker Corporation (BRKR) Increased by AnalystFY2017 EPS Estimates for Bruker Corporation (BRKR) Increased by Analyst
www.americanbankingnews.com - November 6 at 7:14 AM
Bruker Corporation (BRKR) Receives Consensus Recommendation of "Hold" from BrokeragesBruker Corporation (BRKR) Receives Consensus Recommendation of "Hold" from Brokerages
www.americanbankingnews.com - November 5 at 9:30 PM
Bruker Corporation (BRKR) Upgraded to "Neutral" by J P Morgan Chase & CoBruker Corporation (BRKR) Upgraded to "Neutral" by J P Morgan Chase & Co
www.americanbankingnews.com - November 5 at 7:36 PM
Bruker Corporation (BRKR) Lifted to "Neutral" at Bank of America CorporationBruker Corporation (BRKR) Lifted to "Neutral" at Bank of America Corporation
www.americanbankingnews.com - November 5 at 6:58 PM
Citigroup Inc. Raises Bruker Corporation (BRKR) Price Target to $34.00Citigroup Inc. Raises Bruker Corporation (BRKR) Price Target to $34.00
www.americanbankingnews.com - November 4 at 6:06 PM
Bruker Corporations (BRKR) "Hold" Rating Reaffirmed at Cowen and CompanyBruker Corporation's (BRKR) "Hold" Rating Reaffirmed at Cowen and Company
www.americanbankingnews.com - November 3 at 7:50 PM
Bruker (BRKR) Q3 2017 Results - Earnings Call TranscriptBruker (BRKR) Q3 2017 Results - Earnings Call Transcript
seekingalpha.com - November 3 at 5:23 PM
Edited Transcript of BRKR earnings conference call or presentation 2-Nov-17 8:30pm GMTEdited Transcript of BRKR earnings conference call or presentation 2-Nov-17 8:30pm GMT
finance.yahoo.com - November 3 at 8:22 AM
Bruker Corporation (BRKR) Posts  Earnings Results, Beats Estimates By $0.02 EPSBruker Corporation (BRKR) Posts Earnings Results, Beats Estimates By $0.02 EPS
www.americanbankingnews.com - November 2 at 9:29 PM
Noteworthy Thursday Option Activity: BRKR, AAC, NWLNoteworthy Thursday Option Activity: BRKR, AAC, NWL
www.thestreet.com - November 2 at 5:26 PM
What Are Analysts Saying About the future of Bruker Corporation’s (BRKR) Business?What Are Analysts Saying About the future of Bruker Corporation’s (BRKR) Business?
finance.yahoo.com - November 2 at 5:26 PM
Bruker Corporation to Host Earnings CallBruker Corporation to Host Earnings Call
finance.yahoo.com - November 2 at 5:26 PM
Bruker Reports Third Quarter 2017 Financial ResultsBruker Reports Third Quarter 2017 Financial Results
finance.yahoo.com - November 2 at 5:26 PM
Bruker tops Street 3Q forecastsBruker tops Street 3Q forecasts
finance.yahoo.com - November 2 at 5:26 PM
First Week of BRKR June 2018 Options TradingFirst Week of BRKR June 2018 Options Trading
www.nasdaq.com - October 31 at 5:55 PM
Bruker Corporation (BRKR) vs. Its Peers Financial ContrastBruker Corporation (BRKR) vs. Its Peers Financial Contrast
www.americanbankingnews.com - October 28 at 11:40 AM
$414.24 Million in Sales Expected for Bruker Corporation (BRKR) This Quarter$414.24 Million in Sales Expected for Bruker Corporation (BRKR) This Quarter
www.americanbankingnews.com - October 28 at 8:38 AM
Bruker Corporation (BRKR) Set to Announce Earnings on ThursdayBruker Corporation (BRKR) Set to Announce Earnings on Thursday
www.americanbankingnews.com - October 26 at 2:42 AM
FY2017 Earnings Forecast for Bruker Corporation (BRKR) Issued By Jefferies GroupFY2017 Earnings Forecast for Bruker Corporation (BRKR) Issued By Jefferies Group
www.americanbankingnews.com - October 23 at 4:22 AM
Comparing Bruker Corporation (BRKR) and Accuray (ARAY)Comparing Bruker Corporation (BRKR) and Accuray (ARAY)
www.americanbankingnews.com - October 21 at 4:24 AM
Bruker Announces Date and Time of Third Quarter 2017 Earnings Release and WebcastBruker Announces Date and Time of Third Quarter 2017 Earnings Release and Webcast
finance.yahoo.com - October 16 at 5:30 PM
Contrasting Bruker Corporation (BRKR) & Its CompetitorsContrasting Bruker Corporation (BRKR) & Its Competitors
www.americanbankingnews.com - October 12 at 2:26 AM
Bruker Corporation (BRKR) Given Consensus Rating of "Hold" by AnalystsBruker Corporation (BRKR) Given Consensus Rating of "Hold" by Analysts
www.americanbankingnews.com - October 12 at 12:48 AM
Featured Company News - Bruker Introduces Additional Key Products for Diagnosis and Susceptibility Testing of Invasive Fungal DiseasesFeatured Company News - Bruker Introduces Additional Key Products for Diagnosis and Susceptibility Testing of Invasive Fungal Diseases
finance.yahoo.com - October 9 at 5:30 PM
Bruker Introduces Additional Key Products for Diagnosis and Susceptibility Testing of Invasive Fungal Diseases (IFD) into European Clinical Microbiology MarketsBruker Introduces Additional Key Products for Diagnosis and Susceptibility Testing of Invasive Fungal Diseases (IFD) into European Clinical Microbiology Markets
finance.yahoo.com - October 6 at 5:02 PM

SEC Filings

Bruker (NASDAQ:BRKR) SEC Filings

This page is loading this company's SEC Filings. Please wait...

Social Media

Financials

Bruker (NASDAQ:BRKR) Income Statement, Balance Sheet and Cash Flow Statement

Chart

Bruker (NASDAQ BRKR) Stock Chart for Wednesday, December, 13, 2017

Loading chart…

This page was last updated on 12/13/2017 by MarketBeat.com Staff

Enter your email address below to receive a concise daily summary of analysts' upgrades, downgrades and new coverage with MarketBeat.com's FREE daily email newsletter.